Migraines In Women: How Hormones Influence Neurological Health
For those who have not experienced a migraine, perhaps it would seem just another headache. But for someone like me who has suffered through migraines that will last over a week even with medication, I can definitely tell you that it's much more. The ache is not confined to the head; it's the whole experience. Nausea, sensitivity to light, and throbs so bad it makes simple tasks unbearable. It also comes with an emotional burden—the loneliness and frustration are pretty unbearable. Through the years, realizing how hormones are also implicated in triggering and exacerbating my migraines has helped change the game in my dealing with these episodes.
Hormonal migraines are caused by fluctuations in estrogen and progesterone, the two main female hormones. These hormones are essential for the reproductive system, regulating menstrual cycles and pregnancy. They also have an effect on brain chemicals, such as serotonin and dopamine, which affect mood and pain perception. When hormone levels fluctuate, such as during menstruation, pregnancy, or menopause, they can destabilize the pathways in the brain, causing migraines.
According to Dr. Shivananda Pai, Consultant Neurology, migraines are more than a neurological disorder. "Migraines represent a complex interplay of genetic, environmental, and hormonal factors. In women, hormonal fluctuations are a critical trigger that amplifies sensitivity to pain," he explains. Hormonal headaches are particularly challenging because they are influenced by multiple life stages, from puberty to post-menopause. Common causes include:
Estrogen, often called the "hormone of femininity", does more than regulate reproductive functions. It is a powerful influencer of brain health. Estrogen modulates the activity of neurotransmitters like serotonin, which regulates mood and pain perception, and dopamine, associated with reward and pleasure.
During stages of hormonal stability, like in pregnancy's latter months, women may have fewer migraines because of the steady elevation of estrogen. However, a sudden downfall in estrogen destabilizes these chemicals in the brain, sending a heightened sensitivity for migraine triggers.
The most common form of hormonal migraines is menstrual migraines, which occur in response to the steep decline in estrogen levels just before menstruation. These are typically more intense and less responsive to standard treatment. The timing of these migraines provides clear evidence of the role hormones play in neurological health.
Pregnancy is a rollercoaster of hormones. Although many women experience relief from migraines as a result of the constantly elevated levels of estrogen, some women, particularly in the first trimester, worsen. This individual variability is a characteristic of hormonal migraine triggers.
Hormonal treatments, such as oral contraceptives and HRT, have had mixed reviews regarding their use in managing migraine. Some women fare better with the stabilization the treatment provides, whereas others suffer worsening symptoms. This will depend on the nature and dose of the hormones used.
For most women, menopause brings relief from their migraines. The decline in frequency and severity often accompanies stability in hormone levels. Even so, the susceptibility remains with some towards other forms of triggers including stress and sleep deprivation, not to forget diet-related factors and continues the saga of migraines well after the menopausal stages.
The relationship of hormones to neurological health goes beyond migraines. Hormonal changes have profound effects on a woman's brain in general.
Mood Disorders: Estrogen helps stabilize mood by regulating serotonin. Its decline at menopause increases the risk of mood swings and depression.
Neurodegenerative Diseases: Estrogen is neuroprotective, stimulating the growth and repair of brain cells. Its absence in post-menopausal women has been associated with an increased risk of Alzheimer's disease and cognitive decline.
Multiple Sclerosis (MS): Hormonal cycles may affect the course of MS, a disease that occurs more frequently in women than in men. Estrogen's anti-inflammatory effects provide transient protection during pregnancy, reducing relapse rates in women with MS.
"The intricate interplay between hormones and neurological health underscores the need for gender-specific treatment approaches," says Dr. Pai.
While hormonal changes are inevitable, several strategies can help manage migraines effectively:
Understanding your menstrual cycle can help identify patterns and predict when migraines might occur. This knowledge allows for preventive measures, such as scheduling medications or adjusting lifestyle habits.
Working with a neurologist or gynecologist can help develop a personalized treatment plan. Options might include hormonal therapies, triptans, or preventive medications tailored to your specific needs.
A well-balanced diet, regular exercise, and stress management are all integral parts of managing migraines. For instance, magnesium-rich foods and hydration can help reduce the frequency and severity of attacks.
For people with severe or frequent migraines, preventive medications, such as beta-blockers or CGRP inhibitors, may be prescribed. These medications stabilize brain activity and therefore reduce the chances of migraine during hormonal fluctuations.
Techniques like yoga, meditation, and biofeedback can enhance wellness and reduce the debilitating effects of stress-one of the most common migraine triggers.
Research that was once in its embryonic stage continues to shed more light on the role of hormones in migraines and other neurological conditions. Further breakthroughs in genetic testing might enable doctors to predict, at least in a way, how an individual would react to hormonal therapies. The importance of gender-specific approaches is gradually being realized, which involves differentiating between the plight of women with migraines from others.
As Dr. Pai puts it, "Empowering women with knowledge about the hormonal underpinnings of migraines can lead to better, more personalized care. With the right strategies, migraines can be effectively managed, allowing women to lead fuller, healthier lives.
Migraines are not headaches; they are a complex neurological condition that deeply impacts the lives of millions of women. Understanding the role of hormones in triggering and exacerbating migraines is a vital step toward better management and relief.
Awareness, proactive care, and advances in medical research can help women regain their lives from the grip of hormonal migraines. Whether tracking cycles, adopting healthier habits, or seeking tailored medical care, every step taken toward understanding and managing migraines is a step toward empowerment.
Dr Shivananda Pai is a Consultant Neurology at KMC Hospital Dr B R Ambedkar Circle in Mangalore, India.
Brandes JL. The Influence of Estrogen on Migraine: A Systematic Review. JAMA. 2006;295(15):1824–1830. doi:10.1001/jama.295.15.1824
Sacco S, Ricci S, Degan D, Carolei A. Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain. 2012 Apr;13(3):177-89. doi: 10.1007/s10194-012-0424-y. Epub 2012 Feb 26. PMID: 22367631; PMCID: PMC3311830.
Credit: AI generated image
Extremes of heatwaves and ozone pollution are intensifying, increasing heart- and lung disease-related deaths in India, according to a new study.
Heatwaves are associated with heat stress, dehydration, heat exhaustion, heatstroke, and cardiovascular strain, while ground-level ozone is a harmful air pollutant linked to heart and lung diseases and increased mortality.
Researchers from the Indian Institute of Technology (IIT), Kharagpur, found that surface ozone levels reach 85–110 micrograms per cubic meter (μg/m³) in northern India during heatwaves—far exceeding the World Health Organization (WHO) guideline of 70 μg/m³.
The study found that heatwaves significantly intensify exposure to toxic ground-level ozone, a harmful air pollutant linked to heart and lung diseases and increased mortality.
“In 2024 alone, ozone exposure during heatwaves was associated with 15,615 deaths from ischemic heart disease and another 10,898 deaths from chronic obstructive pulmonary disease (COPD),” said researchers Parambat Sangeetha of Kerala University of Fisheries and Ocean Studies and Jayanarayanan Kuttippurath of IIT Kharagpur in the paper.
Overall, ozone exposure during heatwave conditions was associated with more than 26,500 deaths in 2024, according to the study published in npj Clean Air. Before heatwave conditions, ozone exposure was linked to 490 deaths from ischemic heart disease and 342 deaths from COPD.
Surface ozone is not released directly into the atmosphere. Instead, it forms when sunlight triggers chemical reactions among existing pollutants—a process that accelerates during periods of extreme heat.
“Ozone is very harmful, while NO₂ (nitrogen dioxide) and HCHO (formaldehyde) directly damage the respiratory system,” the authors said.
For the study, researchers combined two decades of temperature records from the India Meteorological Department (IMD) with satellite observations and global weather datasets to track ozone levels and the gases responsible for its formation.
Heatwaves between 2004 and 2024 were identified using standard temperature thresholds. The team identified 188 heatwave events over the two-decade period, with the most severe years—2010, 2016, 2019, and 2024—occurring after strong El Niño episodes.
The Western Himalayas recorded the sharpest long-term increase in ozone levels, exceeding WHO guidelines by 115 percent in 2024.
The researchers concluded that “coupled heat–ozone extremes are intensifying, requiring urgent integrated climate–air quality policy action.”
Severe heatwave conditions predominantly affect:
The heatwave belt often expands further into:
The study noted that chronic obstructive pulmonary disease (COPD) is highly sensitive to changes in temperature, humidity, and air quality.
Dr. Amit Kumar Mandal, Senior Director of Pulmonology at Paras Health, explained that extreme heat combined with pollution places significant stress on multiple organs.
“People often think heatwaves only affect the skin or cause dehydration, but when extreme heat combines with high pollution levels, the body starts functioning as if it is constantly under attack,” he told HealthandMe.
“The lungs are forced to work harder to filter hot, polluted air, while the heart simultaneously struggles to regulate body temperature. This invisible overload can quietly trigger inflammation, breathing distress, sudden BP fluctuations, and cardiac strain, even in people who otherwise consider themselves healthy.”
The expert noted that early symptoms are often subtle and may go unnoticed. Common symptoms seen during heatwave and pollution episodes include:
Recommended precautions include:
Credit: AI generated image
The ancient practice of yoga may help improve fertility and hormonal health in women with Polycystic Ovary Syndrome (PCOS), now renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS), according to three studies led by researchers at the All India Institute of Medical Sciences (AIIMS), New Delhi.
PCOS is a multifactorial condition affecting millions of women and involves a complex interplay of reproductive, metabolic, and psychological factors that can significantly impact quality of life.
The condition can increase the risk of serious health complications, including heart disease, diabetes, hypertension, infertility, and, in some cases, cancer.
The studies, led by Dr. Rima Dada, Professor at the Laboratory for Molecular Reproduction and Genetics, Department of Anatomy, AIIMS Delhi, recommend lifestyle modifications, including yoga, as a primary approach to managing the condition.
“Yoga presents a comprehensive strategy for addressing PCOS, targeting hormonal imbalances, OS, mitochondrial function, metabolic syndrome, microRNA regulation, cellular longevity, and mental well‑being. It exemplifies the potential of mind‑body medicine in the treatment of complex disorders,” the researchers said, in the papers.
The papers were published in the Journal of Ayurveda and Integrative Medicine, The International Journal of Ayurveda Research and the International Journal of Yoga.

The three studies involved more than 100 women and followed participants for up to 12 weeks. Participants practiced Asanas (physical postures), Pranayama (breathing techniques), and Dhyana (meditation) for 90 minutes a day, five days a week. The results showed significant improvements across multiple health parameters.
Women with PCOS who participated in the yoga intervention demonstrated significant reductions in:
Also read: Yoga Shows Promise for Anxiety Relief And Seizure Control In Epilepsy, Claims AIIMS Study
“This hormonal balance has led to the restoration of menstrual cycles and improvements in hirsutism and acne, resulting in enhancements in physical appearance and psychological well-being,” the researchers stated.
The studies also found that yoga helped regulate cellular oxidative stress, offering protection against DNA damage and epigenetic changes. Researchers also reported improvements in several metabolic markers, including reductions in:
These findings highlight yoga's potential to address key mechanisms underlying PCOS and support its use as a cost-effective, non-pharmacological, and sustainable therapy for managing the condition.
The studies also found that yoga helped alleviate symptoms of depression among women with PCOS, suggesting it may serve as an effective complementary therapy in managing the condition.
Researchers concluded that regular yoga practice could help prevent, delay, and manage PCOS symptoms.
Read More: India Launches New Yoga Protocols To Fight Diabetes, High BP, Asthma
PCOS is a complex lifestyle disorder that appears to primarily affect the ovaries but is increasingly recognized as a systemic condition affecting multiple organs and body systems.
If not diagnosed and managed early, it can contribute to serious health complications, including non-alcoholic fatty liver disease (NAFLD), cardiovascular disease, hypertension, and Alzheimer's disease.
While treatments such as anti-androgen medications, insulin-sensitizing agents, and fertility therapies remain important, experts note that PCOS also has a strong psychosomatic component that can benefit from lifestyle and mind-body interventions.
PCOS affects more than 170 million women worldwide. In May, it was officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS).
The new name reflects a major shift in understanding the condition—from a predominantly gynecological disorder to a complex multisystem condition affecting several aspects of health. The term PMOS acknowledges that the condition affects:
While back pain alone is rarely a sign of kidney cancer, certain accompanying symptoms should raise concern. (Photo credit: iStock)
Back pain is one of the most common health complaints worldwide, affecting a large proportion of adults at some point in their lives. In most cases, it is caused by benign musculoskeletal issues such as muscle strain, poor posture, or disc-related problems, and it tends to improve with rest, physiotherapy, or simple medication. However, not all back pain originates from the spine. In some situations, pain felt in the lower back or flank region may be linked to underlying kidney conditions, including kidney cancer. As renal cell carcinoma often progresses silently in its early stages, symptoms may be delayed, making it important to recognise when back pain is unusual.
Dr Raj Nagarkar, Chief Surgical Oncologist at HCG Manavata Cancer Centre, Nashik, said, "The kidneys are located deep in the upper abdomen, on either side of the spine, just below the rib cage. When a tumour develops in this region, it can cause pain through several mechanisms. As the tumour grows, it may stretch the kidney’s outer fibrous capsule, leading to a persistent, dull ache in the flank area between the ribs and hip. In some cases, fragile tumour blood vessels may bleed internally or form clots that obstruct urine flow, resulting in sudden, sharp pain that can resemble renal colic. Larger tumours may also press on surrounding nerves or structures, producing discomfort that may be mistaken for back or abdominal pain."
Unlike musculoskeletal pain, which typically improves with movement or rest, kidney-related pain is often constant, may worsen at night, and does not respond well to routine pain relief or physiotherapy.
While back pain alone is rarely a sign of kidney cancer, certain accompanying symptoms should raise concern. One of the most important warning signs is blood in the urine, which may appear pink, red, or dark brown and can sometimes be intermittent. Persistent flank pain associated with a palpable mass under the ribs may indicate more advanced disease. Unexplained weight loss, ongoing fatigue, or a general sense of weakness can reflect systemic illness. Some patients may experience intermittent fever without infection, new-onset high blood pressure, or swelling in the legs and ankles due to impaired venous drainage. Anaemia-related symptoms such as dizziness, breathlessness, or pallor may also be present. When back pain persists beyond a few weeks and is accompanied by any of these features, further medical evaluation is strongly recommended.
It is also important to distinguish kidney-related pain from common musculoskeletal back pain. Mechanical back pain is usually localised to the lower back, may radiate to the legs, and often begins after physical strain or injury. It tends to improve with rest, heat application, or physiotherapy. In contrast, kidney cancer pain is typically one-sided, located higher in the flank below the ribs, and develops gradually without a clear trigger. It is often persistent, may disturb sleep, and is not relieved by standard pain management approaches. Unlike spinal pain, it is more likely to be associated with systemic symptoms such as haematuria, weight loss, or fatigue.
Certain individuals are at higher risk of developing kidney cancer and should be particularly attentive to persistent flank pain. Risk factors include smoking, which significantly increases exposure to kidney-damaging toxins, obesity, long-standing hypertension, chronic kidney disease or dialysis, and a family history of kidney cancer or genetic conditions such as von Hippel-Lindau disease. Occupational exposure to industrial chemicals like trichloroethylene or cadmium may also contribute to risk. When multiple risk factors are present, even mild or persistent symptoms should not be ignored.
If warning signs are suspected, doctors typically begin evaluation with simple and non-invasive tests. A urine analysis can detect microscopic or visible blood, while blood tests help assess kidney function, anaemia, and calcium levels. Imaging plays a crucial role, with ultrasound often used as the first-line investigation, followed by a contrast-enhanced CT scan for detailed evaluation of tumour size and spread. In selected cases, a biopsy may be performed, although it is not always required before treatment.
Treatment outcomes for kidney cancer have improved significantly in recent years. In early-stage disease, partial nephrectomy allows removal of the tumour while preserving healthy kidney tissue, often using minimally invasive or robotic techniques that support faster recovery. In more advanced cases, targeted therapies and immunotherapy help control disease progression and improve quality of life, with many patients able to maintain daily activities during treatment. For small, slow-growing tumours in selected individuals, active surveillance may be an appropriate option.
While most back pain is benign and related to musculoskeletal causes, persistent or unusual pain, especially when accompanied by symptoms such as blood in the urine, unexplained weight loss, or systemic changes, should not be ignored. Kidney cancer often develops silently, and early signs can be subtle. Unlike muscular pain, which is typically movement-related and self-limiting, kidney-related pain is deeper, more persistent, and often associated with other warning features.
© 2024 Bennett, Coleman & Company Limited